Veralipride

This classification denotes an antipsychotic agent with the molecular formula C17H25N3O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier S7064109UD, chemically known as n-((1-allyl-2-pyrrolidinyl)methyl)-2,3-dimethoxy-5-sulfamoylbenzamid but generally known as veralipride, which bears US NIH Compound Identifier 47979. European Medicines Agency schedules Veralipride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00037MIG. World Health Organization schedules veralipride in its Anatomical Therapeutic Chemical (ATC) Classification. VERALIPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule veralipride under HS 29350090 and SITC 51580. As of Q4 2014, VERALIPRIDE remains the US FDA Preferred Term for this commodity. SMILES: S(=O)(=O)(N)C1CC(C(=O)NCC2N(CCC2)CC=C)C(OC)C(OC)C1.